We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRM icon
51
Salesforce
CRM
$134B
$43.8M 0.59%
505,497
+48,488
+11% +$4.22M
EXPE icon
52
Expedia Group
EXPE
$31.2B
$42.8M 0.58%
287,126
+5,360
+2% +$752K
CYBR
53
DELISTED
CyberArk
CYBR
$42.6M 0.57%
853,718
+124,785
+17% +$6.3M
ESNT icon
54
Essent Group
ESNT
$6.06B
$42.5M 0.57%
1,144,700
+37,000
+3% +$1.36M
ADBE icon
55
Adobe
ADBE
$89.5B
$42.4M 0.57%
299,723
-2,000
-0.7% -$274K
SPLK
56
DELISTED
Splunk Inc
SPLK
$42.3M 0.57%
742,803
-121,235
-14% -$7.54M
HOLX
57
DELISTED
Hologic
HOLX
$42M 0.57%
925,940
+855,940
+1,223% +$37.8M
ACN icon
58
Accenture
ACN
$89.9B
$41.2M 0.55%
333,363
– –
LVNTA
59
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$40.9M 0.55%
782,532
-460,548
-37% -$24.1M
LEXEA
60
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$39.5M 0.53%
731,210
– –
CPA icon
61
Copa Holdings
CPA
$5.56B
$39.4M 0.53%
336,649
+196,018
+139% +$22.6M
PFPT
62
DELISTED
Proofpoint, Inc.
PFPT
$38.8M 0.52%
446,463
-132,374
-23% -$10.9M
MHK icon
63
Mohawk Industries
MHK
$6.9B
$38.1M 0.51%
+157,552
New +$37.2M
KITE
64
DELISTED
Kite Pharma, Inc.
KITE
$37.3M 0.5%
+360,000
New +$29.4M
IPG
65
DELISTED
Interpublic Group of Companies
IPG
$36.9M 0.5%
1,501,704
– –
RVTY icon
66
Revvity
RVTY
$12.3B
$36.8M 0.5%
540,619
+319,550
+145% +$19.9M
PGR icon
67
Progressive
PGR
$124B
$36.7M 0.49%
831,700
+56,700
+7% +$2.35M
PYPL icon
68
PayPal
PYPL
$49.5B
$36.6M 0.49%
682,089
+575,033
+537% +$28.3M
ACRS icon
69
Aclaris Therapeutics
ACRS
$730M
$36.5M 0.49%
1,346,049
+375,000
+39% +$10.2M
JAZZ icon
70
Jazz Pharmaceuticals
JAZZ
$15.9B
$36.2M 0.49%
+232,518
New +$35.6M
XLNX
71
DELISTED
Xilinx Inc
XLNX
$36.1M 0.49%
560,665
+17,141
+3% +$1.08M
OXFD
72
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$35.4M 0.48%
2,102,477
+47,108
+2% +$704K
ATVI
73
DELISTED
Activision Blizzard
ATVI
$35.2M 0.47%
611,414
+4,961
+0.8% +$274K
WRB icon
74
W.R. Berkley
WRB
$28B
$34.9M 0.47%
1,701,000
+146,812
+9% +$2.97M
RVNC
75
DELISTED
Revance Therapeutics, Inc.
RVNC
$34.2M 0.46%
1,296,371
– –
1 2
3
4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.